Menu
  • Join
  • Login
  • Contact
 

Search abstracts


An survey of therapeutic drug monitor of prophylactic voriconazole for children with cancer

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: TSAI, Ching-Yi (MacKay Memorial Hospital, Pharmacy)
  • Co-author(s): Ching-Yi Tsai: Division of Clinical Pharmacy, Department of Pharmacy, MacKay Memorial Hospital, Taipei, Taiwan, Province of China
    Chien-Hung Lu
    Wei-Ying Lee
    Ting-Chi Yeh: Division Hematology/Oncology, Department of Pediatrics, MacKay Memorial Hospital, Taipei, Taiwan, Province of China
  • Abstract:

    Background

    Children with cancer receiving intensive chemotherapy are at high risk for invasive fungal infection. The benefit of preventing life-threatening fungal infection by prophylactic voriconazole (VCZ) in children with cancer was proven. The relationship between therapeutic drug monitor (TDM) of prophylactic VCZ and breakthrough fungal..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses